Barry D. Quart - 29 Jun 2022 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
29 Jun 2022
Transactions value $
$0
Form type
4
Filing time
30 Jun 2022, 16:22:01 UTC
Previous filing
15 Apr 2022
Next filing
15 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +30K $0.00 30K 29 Jun 2022 Class A Common Shares 30K $9.88 Direct F1
transaction KNSA Restricted Share Units Award $0 +5K $0.00 5K 29 Jun 2022 Class A Common Shares 5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2022.
F2 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F3 The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022.